{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:31:32Z","timestamp":1780677092789,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012164","name":"863 Program","doi-asserted-by":"crossref","award":["2013ZX09102034"],"award-info":[{"award-number":["2013ZX09102034"]}],"id":[{"id":"10.13039\/501100012164","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.virol.2015.10.029","type":"journal-article","created":{"date-parts":[[2016,1,5]],"date-time":"2016-01-05T13:52:57Z","timestamp":1452001977000},"page":"165-172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["A novel rabies vaccine based-on toll-like receptor 3 (TLR3) agonist PIKA adjuvant exhibiting excellent safety and efficacy in animal studies"],"prefix":"10.1016","volume":"489","author":[{"given":"Yi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoufeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongliang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lietao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2015.10.029_bib1","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1182\/blood-2008-07-019307","article-title":"TLRs and innate immunity","volume":"113","author":"Beutler","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.virol.2015.10.029_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-1759(97)00212-3","article-title":"Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody","volume":"212","author":"Cliquet","year":"1998","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.virol.2015.10.029_bib3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12250-011-3183-z","article-title":"PIKA provides an adjuvant effect to induce strong mucosal and systemic humoral immunity against SARS-CoV","volume":"26","author":"Gai","year":"2011","journal-title":"Virol. Sin."},{"key":"10.1016\/j.virol.2015.10.029_bib4","first-page":"A6443","article-title":"Liver disorders in adults: ALT and AST","volume":"157","author":"Goorden","year":"2013","journal-title":"Ned. tijdschr.\u00a0geneeskd."},{"key":"10.1016\/j.virol.2015.10.029_bib5","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1128\/JVI.03656-14","article-title":"Parainfluenza virus 5 expressing the g protein of rabies virus protects mice after rabies virus infection","volume":"89","author":"Huang","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.10.029_bib6","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0264-410X(90)90084-Y","article-title":"Studies on cell-mediated immune response to rabies virus immunization in dogs","volume":"8","author":"Jayakumar","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2015.10.029_bib7","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.it.2014.06.004","article-title":"T cell mediated immunity to influenza: mechanisms of viral control","volume":"35","author":"La Gruta","year":"2014","journal-title":"Trends Immunol."},{"key":"10.1016\/j.virol.2015.10.029_bib8","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.vaccine.2008.12.048","article-title":"A TLR3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic","volume":"27","author":"Lau","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2015.10.029_bib9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.virol.2010.07.008","article-title":"Activation of the innate immune system provides broad-spectrum protection against influenza A viruses with pandemic potential in mice","volume":"406","author":"Lau","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.virol.2015.10.029_bib10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF01378634","article-title":"A new immunostimulatory complex (PICKCa) in experimental rabies: antiviral and adjuvant effects","volume":"131","author":"Lin","year":"1993","journal-title":"Arch. Virol."},{"key":"10.1016\/j.virol.2015.10.029_bib11","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1016\/j.vaccine.2012.01.092","article-title":"Repeated dose intramuscular injection of the CIMAvax-EGF vaccine in Sprague Dawley rats induces local and systemic toxicity","volume":"30","author":"Mancebo","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2015.10.029_bib12","unstructured":"Manning, S.E., Rupprecht, C.E., Fishbein, D., Hanlon, C.A., Lumlertdacha, B., Guerra, M., Meltzer, M.I., Dhankhar, P., Vaidya, S.A., Jenkins, S.R., Sun, B., Hull, H.F., Advisory Committee on Immunization Practices Centers for Disease, C., Prevention, 2008. Human rabies prevention\u2013United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR. Recommendations and Reports: Morbidity and Mortality Weekly Report. Recommendations and reports\/Centers for Disease Control 57, pp. 1\u201328."},{"key":"10.1016\/j.virol.2015.10.029_bib13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1473-3099(02)00287-6","article-title":"Rabies re-examined","volume":"2","author":"Rupprecht","year":"2002","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virol.2015.10.029_bib14","first-page":"113","article-title":"PIKA as an adjuvant enhances specific humoral and cellular immune responses following the vaccination of mice with HBsAg plus PIKA","volume":"4","author":"Shen","year":"2007","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.virol.2015.10.029_bib15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12199-010-0181-y","article-title":"Effect of fluoride exposure on bone metabolism indicators ALP, BALP, and BGP","volume":"16","author":"Song","year":"2011","journal-title":"Environ. Health Prev. Med."},{"key":"10.1016\/j.virol.2015.10.029_bib16","first-page":"51","article-title":"[Liver function tests: analysis of serum isoenzymes--GOT, LDH, ALP, gamma-GTP and ChE]","volume":"34","author":"Suzuki","year":"1986","journal-title":"Rinsho Byori\u00a0Jpn. J. Clin. Pathol."},{"key":"10.1016\/j.virol.2015.10.029_bib17","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1016\/j.vaccine.2014.07.087","article-title":"Complete protection against lethal challenge of novel H7N9 virus with heterologous inactivated H7 vaccine in mice","volume":"32","author":"Tang","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2015.10.029_bib18","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/clin.1994.1088","article-title":"Long-term humoral and cellular immunity after vaccination with cell culture rabies vaccines in man","volume":"71","author":"Thraenhart","year":"1994","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.virol.2015.10.029_bib19","doi-asserted-by":"crossref","first-page":"750374","DOI":"10.1155\/2014\/750374","article-title":"Cellular factors targeting APCs to modulate adaptive T cell immunity","volume":"2014","author":"Visperas","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.virol.2015.10.029_bib20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/nyas.12445","article-title":"Regulation of immune responses by neutrophils","volume":"1319","author":"Wang","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.virol.2015.10.029_bib21","first-page":"1","article-title":"A new PIKA adjuvant rabies vaccine\u2014the therapeutic vaccine for life rescue","volume":"16","author":"Wang","year":"2010","journal-title":"J. Appl. Prev. Med."},{"key":"10.1016\/j.virol.2015.10.029_bib22","first-page":"564","article-title":"Rabies","volume":"3","author":"Warrell","year":"1997","journal-title":"Clin. Microbiol. Infect. \u2013 Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.virol.2015.10.029_bib23","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.coviro.2013.06.012","article-title":"The distinct role of T cell costimulation in antiviral immunity","volume":"3","author":"Welten","year":"2013","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.virol.2015.10.029_bib24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1086\/324628","article-title":"Postexposure treatment of rabies infection: can it be done without immunoglobulin?","volume":"34","author":"Wilde","year":"2002","journal-title":"Clin. Infect. Dis.\u00a0\u2013 Off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.virol.2015.10.029_bib25","unstructured":"World Health Organization, 2011. The Immunological Basis for Immunization Series: Module 17: Rabies."},{"key":"10.1016\/j.virol.2015.10.029_bib26","unstructured":"World Health Organization, 2013. WHO Expert Consultation on Rabies. Second report. World Health Organization technical report series, pp. 1\u2013139, back cover."},{"key":"10.1016\/j.virol.2015.10.029_bib27","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00705-012-1556-8","article-title":"Adjuvant PIKA protects hepatoma cells from dengue virus infection by promoting a TBK-1-dependent innate immune response","volume":"158","author":"Zhang","year":"2013","journal-title":"Arch. Virol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682215004572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682215004572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:34:44Z","timestamp":1758587684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682215004572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":27,"alternative-id":["S0042682215004572"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2015.10.029","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel rabies vaccine based-on toll-like receptor 3 (TLR3) agonist PIKA adjuvant exhibiting excellent safety and efficacy in animal studies","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2015.10.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}